This afternoon, BIO was officially launched on four major exchanges, namely Binance, Huobi, Ouyi and Zhima Kaitong. It is not common for projects to be launched on so many major platforms at the same time. Recently, a similar situation happened to the Move project. When it was launched, the price was only $0.01, and it rose sharply to $1.16 the next day, and once exceeded $1.22, an increase of 122 times. So, can BIO also become the next 100-fold project?
The BIO protocol belongs to the field of DeSci (decentralized science). Its goal is to accelerate the inflow of capital and talent and promote the application of blockchain in scientific research. The BIO protocol raises funds for BIO DAO through auction contracts, which will be used to support scientific research, the acquisition of intellectual property rights, and various projects in the field of biotechnology. BIO is committed to breaking the centralized structure of traditional scientific research, especially in the process of fund management, data storage, and results release, reducing the intervention of intermediaries, so that scientific research results can be distributed and shared more fairly.
As the financial layer in the DeSci field, BIO's core function is to accelerate the research and development of biotechnology. It allows patients, scientists, and biotechnology experts from around the world to jointly fund and own tokenized biotechnology projects. The research outcomes of these projects are recorded and tokenized through blockchain technology, ensuring the openness and transparency of the research process. In the past, drug development in the biopharmaceutical industry was often closed off, whereas BIO breaks through this limitation through a decentralized approach, enabling the sharing of research achievements and enhancing the efficiency and transparency of scientific research.
The BIO project has received full investment support from Binance Labs, which undoubtedly boosts market confidence. BIO completed its first round of financing of $6.22 million in August 2024 and a community token financing of $4.74 million in November. This financing provides strong financial support for the further development of the project.
From the market valuation perspective, the total issuance of BIO is 3.32 billion tokens, with a current valuation of approximately $21.9 million. If the price of BIO is below $0.08, the entry risk is relatively low. However, during a bull market, many new coins often experience a short-term surge when they go live, which may be followed by a price correction. Therefore, everyone needs to enter cautiously, paying attention to the auction price and the market performance after the official launch.
Overall, BIO has attracted a lot of attention with its innovative decentralized scientific research concept and strong investment background. Nevertheless, investing in new coins always comes with risks, especially in times of market volatility. Whether BIO can experience a surge like Move remains to be seen over time. For all investors, the most important thing is to remain cautious, observe market trends, and make decisions after reasonably assessing risks.
